- Home
- CMPX vs HLXB Comparison
CMPX vs HLXB Comparison
Compare CMPX & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- HLXB
- Stock Information
- Founded
- CMPX 2014
- HLXB 2021
- Country
- CMPX United States
- HLXB United States
- Employees
- CMPX N/A
- HLXB N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- HLXB
- Sector
- CMPX Health Care
- HLXB
- Exchange
- CMPX Nasdaq
- HLXB NYSE
- Market Cap
- CMPX 206.3M
- HLXB 245.7M
- IPO Year
- CMPX N/A
- HLXB 2024
- Fundamental
- Price
- CMPX $1.42
- HLXB $10.80
- Analyst Decision
- CMPX Strong Buy
- HLXB
- Analyst Count
- CMPX 3
- HLXB 0
- Target Price
- CMPX $7.67
- HLXB N/A
- AVG Volume (30 Days)
- CMPX 421.2K
- HLXB 12.3K
- Earning Date
- CMPX 11-12-2024
- HLXB 01-01-0001
- Dividend Yield
- CMPX N/A
- HLXB N/A
- EPS Growth
- CMPX N/A
- HLXB N/A
- EPS
- CMPX N/A
- HLXB N/A
- Revenue
- CMPX $850,000.00
- HLXB N/A
- Revenue This Year
- CMPX N/A
- HLXB N/A
- Revenue Next Year
- CMPX $610.48
- HLXB N/A
- P/E Ratio
- CMPX N/A
- HLXB N/A
- Revenue Growth
- CMPX N/A
- HLXB N/A
- 52 Week Low
- CMPX $0.77
- HLXB $10.03
- 52 Week High
- CMPX $2.34
- HLXB $10.85
- Technical
- Relative Strength Index (RSI)
- CMPX 41.28
- HLXB N/A
- Support Level
- CMPX $1.44
- HLXB N/A
- Resistance Level
- CMPX $1.58
- HLXB N/A
- Average True Range (ATR)
- CMPX 0.12
- HLXB 0.00
- MACD
- CMPX -0.01
- HLXB 0.00
- Stochastic Oscillator
- CMPX 11.63
- HLXB 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.